{"id":411082,"date":"2021-01-08T08:24:33","date_gmt":"2021-01-08T13:24:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=411082"},"modified":"2021-01-08T08:24:33","modified_gmt":"2021-01-08T13:24:33","slug":"dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/","title":{"rendered":"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021"},"content":{"rendered":"

<\/p>\n

Dr. Reddy’s to Release Q3 FY 21 Results on January 29th<\/sup>, 2021<\/b><\/p>\n

Earnings call slated for January 29th<\/sup> @ 5:30 PM IST \/ 7:00 AM EST<\/b><\/p>\n

HYDERABAD, India–(BUSINESS WIRE<\/a>)–
\nDr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the third quarter ended December 31, 2020 on Friday, January 29th<\/sup>, 2021 after the Board Meeting.\n<\/p>\n

Summary of Events<\/b><\/p>\n\n\n\n\n\n\n\n
\n

Event<\/b><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

Date and Time<\/b><\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

Medium<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nRelease of financial results\n<\/p>\n<\/td>\n

\n\n\n

\nJanuary 29th<\/sup>, after the Board Meeting\n<\/p>\n<\/td>\n

\n\n\n

\nStock Exchange, Media, Company website, Business wire, Email\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPress meet presentation\n<\/p>\n<\/td>\n

\n\n\n

\nWill be available on the Company\u2019s website\n<\/p>\n<\/td>\n

\n\n\n

\nCompany\u2019s website www.drreddys.com<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

\nEarnings Call\n<\/p>\n<\/td>\n

\n\n\n

\nJanuary 29th<\/sup>, 5:30 PM IST \/ 7:00 AM EST\n<\/p>\n<\/td>\n

\n\n\n

\nHosted by the Company (Details below)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPlayback of Earnings Call\n<\/p>\n<\/td>\n

\n\n\n

\nAfter the earnings call till February 5th<\/sup>, 2021\n<\/p>\n<\/td>\n

\n\n\n

\nDetails below\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTranscript of the Earnings call\n<\/p>\n<\/td>\n

\n\n\n

\nWill be available on the Company\u2019s website\n<\/p>\n<\/td>\n

\n\n\n

\nCompany\u2019s website www.drreddys.com<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Earnings Call <\/b><\/p>\n

\nFollowing the release, the management of the Company will host an earnings call to discuss the Company\u2019s financial performance. (Dial In and other details given below)<\/i><\/p>\n

Play Back <\/b><\/p>\n

\nThe play back will be available after the earnings call, till February 5th<\/sup>, 2021. For play back dial in phone No: +91 22 7194 5757 | +91 22 6663 5757, and Playback Code is 37918.\n<\/p>\n

Conference Joining Information<\/b><\/p>\n\n\n
\n

Option 1: Express Join with DiamondPass\u2122 <\/b><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nPre-register with the below link and join without waiting for the operator.\n<\/p>\n

https:\/\/services.choruscall.in\/DiamondPassRegistration\/register?confirmationNumber=9941549&linkSecurityString=1ea6b66bb2<\/a><\/p>\n\n\n\n\n\n
\n

Option 2: Join through below Dial-In Numbers <\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nUniversal Access Number:\n<\/p>\n

\n\u00a0\n<\/p>\n<\/td>\n

\n\n\n

+91 22 6280 1219<\/b><\/p>\n

+91 22 7115 8120<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nLocal Access Number:\n<\/p>\n

Available all over India<\/i><\/p>\n<\/td>\n

\n\n\n

+91 70456 71221<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nInternational Toll Free Number:\n<\/p>\n<\/td>\n

\n\n\n

\nUSA: 1 866 746 2133<\/b><\/p>\n

\nUK: 0 808 101 1573<\/b><\/p>\n

\nSingapore: 800 101 2045<\/b><\/p>\n

\nHong Kong: 800 964 448<\/b><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nNo password\/pin number is necessary to dial in to any of the above numbers. The operator will provide instructions on asking questions before and during the call.\n<\/p>\n

About Dr. Reddy\u2019s: <\/b>Dr. Reddy\u2019s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products \u2013 Dr. Reddy\u2019s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy\u2019s operates in markets across the globe. Our Major markets include \u2013 USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com<\/a><\/p>\n

Disclaimer: <\/strong>This press release may include statements of future expectations and other forward-looking statements that are based on the management\u2019s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may”, “will”, “should”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency \/ severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and\/or governments, (v) the impact of acquisitions or reorganization , including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers\u2019, products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the “Risk Factors” and “Forward-Looking Statements” sections of our Annual Report on Form 20-F for the year ended March 31, 2020. The company assumes no obligation to update any information contained herein.\u201d\n<\/p>\n

\nThe company assumes no obligation to update any information contained herein.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210108005292\/en\/<\/a><\/span><\/p>\n

INVESTOR RELATIONS
\n
<\/b>AMIT AGARWAL
amita@drreddys.com
\n<\/a>
(Ph: +91-40-49002135)
\n<\/p>\n

MEDIA RELATIONS
\n<\/b>
APARNA TEKURI
\n
aparnatekuri@drreddys.com
\n<\/a>
(PH: +91-40-49002446)\n<\/p>\n

KEYWORDS:<\/b> India Asia Pacific<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021 Earnings call slated for January 29th @ 5:30 PM IST \/ 7:00 AM EST HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the third quarter ended December 31, 2020 on Friday, January 29th, 2021 after the Board Meeting. Summary of Events Event \u00a0 \u00a0 Date and Time \u00a0 \u00a0 Medium Release of financial results January 29th, after the Board Meeting Stock Exchange, Media, Company website, Business wire, Email Press meet presentation Will be available on the Company\u2019s website Company\u2019s website www.drreddys.com Earnings Call January 29th, 5:30 PM IST \/ 7:00 AM EST Hosted by the Company (Details … <\/p>\n

Continue reading “Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-411082","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021 Earnings call slated for January 29th @ 5:30 PM IST \/ 7:00 AM EST HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the third quarter ended December 31, 2020 on Friday, January 29th, 2021 after the Board Meeting. Summary of Events Event \u00a0 \u00a0 Date and Time \u00a0 \u00a0 Medium Release of financial results January 29th, after the Board Meeting Stock Exchange, Media, Company website, Business wire, Email Press meet presentation Will be available on the Company\u2019s website Company\u2019s website www.drreddys.com Earnings Call January 29th, 5:30 PM IST \/ 7:00 AM EST Hosted by the Company (Details … Continue reading "Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-08T13:24:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021\",\"datePublished\":\"2021-01-08T13:24:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/\"},\"wordCount\":717,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/\",\"name\":\"Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-08T13:24:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 - Market Newsdesk","og_description":"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021 Earnings call slated for January 29th @ 5:30 PM IST \/ 7:00 AM EST HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the third quarter ended December 31, 2020 on Friday, January 29th, 2021 after the Board Meeting. Summary of Events Event \u00a0 \u00a0 Date and Time \u00a0 \u00a0 Medium Release of financial results January 29th, after the Board Meeting Stock Exchange, Media, Company website, Business wire, Email Press meet presentation Will be available on the Company\u2019s website Company\u2019s website www.drreddys.com Earnings Call January 29th, 5:30 PM IST \/ 7:00 AM EST Hosted by the Company (Details … Continue reading \"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-08T13:24:33+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021","datePublished":"2021-01-08T13:24:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/"},"wordCount":717,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/","name":"Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-08T13:24:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210108005292r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-to-release-q3-fy-21-results-on-january-29th-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dr. Reddy’s to Release Q3 FY 21 Results on January 29th, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=411082"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411082\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=411082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=411082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=411082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}